Vesicular Stomatitis Virus Oncolytic Treatment Interferes with Tumor-Associated Dendritic Cell Functions and Abrogates Tumor Antigen Presentation
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vesicular Stomatitis Virus Oncolytic Treatment Interferes with Tumor-Associated Dendritic Cell Functions and Abrogates Tumor Antigen Presentation
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 85, Issue 23, Pages 12160-12169
Publisher
American Society for Microbiology
Online
2011-09-15
DOI
10.1128/jvi.05703-11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy
- (2011) S Leveille et al. CANCER GENE THERAPY
- IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells
- (2011) J. E. Boudreau et al. CANCER RESEARCH
- Activating Systemic T-Cell Immunity Against Self Tumor Antigens to Support Oncolytic Virotherapy with Vesicular Stomatitis Virus
- (2011) Phonphimon Wongthida et al. HUMAN GENE THERAPY
- Targeting Tumor Vasculature With an Oncolytic Virus
- (2011) Caroline J Breitbach et al. MOLECULAR THERAPY
- Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors
- (2011) Timothy Kottke et al. NATURE MEDICINE
- Oncolytic Viruses Move Forward in Clinical Trials
- (2010) K. Rowan JNCI-Journal of the National Cancer Institute
- Potentiating Cancer Immunotherapy Using an Oncolytic Virus
- (2010) Byram W Bridle et al. MOLECULAR THERAPY
- Oncolytic Viruses: An Approved Product on the Horizon?
- (2010) John Bell MOLECULAR THERAPY
- VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 Signaling
- (2010) Phonphimon Wongthida et al. MOLECULAR THERAPY
- Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide
- (2010) Candice Willmon et al. MOLECULAR THERAPY
- Expression of IFN- Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma
- (2009) C. L. Willmon et al. CANCER RESEARCH
- Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma
- (2009) F Galivo et al. GENE THERAPY
- The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon
- (2009) Robin J. Prestwich et al. HUMAN GENE THERAPY
- Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus
- (2009) Feorillo Galivo et al. HUMAN GENE THERAPY
- Vesicular Stomatitis Virus M Protein Mutant Stimulates Maturation of Toll-Like Receptor 7 (TLR7)-Positive Dendritic Cells through TLR-Dependent and -Independent Mechanisms
- (2009) M. Ahmed et al. JOURNAL OF VIROLOGY
- Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus
- (2009) Byram W Bridle et al. MOLECULAR THERAPY
- Recombinant Vesicular Stomatitis Virus Transduction of Dendritic Cells Enhances Their Ability to Prime Innate and Adaptive Antitumor Immunity
- (2009) Jeanette E Boudreau et al. MOLECULAR THERAPY
- Migration of Dendritic Cell Subsets and their Precursors
- (2007) Gwendalyn J. Randolph et al. Annual Review of Immunology
- Tumor-induced modulation of dendritic cell function
- (2007) E GOTTFRIED et al. CYTOKINE & GROWTH FACTOR REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now